The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Source: TechCrunch
🔑 Key Takeaways
- Wire dispatch directly ingested from TechCrunch.
- Published at Wed, 23 Sep 2026 19:31.
- Source URL: https://techcrunch.com/2026/09/23/enveda-secures-311m-to-bring-more-nature-derived-ai-drugs-into-clinical-trials/